Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1383, 2012-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The US FDA has approved acetadote [acetylcysteine] labelling updates
Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. :
Access to resources
Recommend
FDA review of Arcoxia and Prexige shows potential CV risk
Reactions Weekly, Vol. 1, Iss. 1038, 2005-01 ,pp. :
Analysis prompted by FDA shows varenicline's CV safety risk is low
Reactions Weekly, Vol. 1, Iss. 1433, 2013-01 ,pp. :
US FDA announces ongoing assessment of CV risk for Stalevo
Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. :